| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744491 | Anaerobe | 2018 | 11 Pages |
Abstract
CBM 588 treatment modulated the gut microbiota composition under dysbiosis due to the use of an antimicrobial with strong activity against anaerobes and significantly reduced epithelial damage.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Mao Hagihara, Rieko Yamashita, Asami Matsumoto, Takeshi Mori, Yasutoshi Kuroki, Hayami Kudo, Kentaro Oka, Motomichi Takahashi, Tsunemasa Nonogaki, Yuka Yamagishi, Hiroshige Mikamo,